Literature DB >> 7488619

Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.

D D Lasic1, B Ceh, M C Stuart, L Guo, P M Frederik, Y Barenholz.   

Abstract

Phase transitions in closed vesicles, i.e., microenvironments defined by the size of the vesicle, its contents, and permeability of its membrane are becoming increasingly important in several scientific disciplines including catalysis, growth of small crystals, cell function studies, and drug delivery. The membrane composed from lipid bilayer is in general impermeable to ions and larger hydrophilic ions. Ion transport can be regulated by ionophores while permeation of neutral and weakly hydrophobic molecules can be controlled by concentration gradients. Some weak acids or bases, however, can be transported through the membrane due to various gradients, such as electrical, ionic (pH) or specific salt (chemical potential) gradients. Upon permeation of appropriate species and reaction with the encapsulated species precipitation may occur in the vesicle interior. Alternatively, these molecules can also associate with the leaflets of the bilayer according to the transmembrane potential. Efficient liposomal therapeutics require high drug to lipid ratios and drug molecules should have, especially when associated with long circulating liposomes, low leakage rates. In this article we present very efficient encapsulation of two drugs via their intraliposomal precipitation, characterize the state of encapsulated drug within the liposome and try to fit the experimental data with a recently developed theoretical model. Nice agreement between a model which is based on chemical potential equilibration of membrane permeable species with experimental data was observed. The high loading efficiencies, however are only necessary but not sufficient condition for effective therapies. If adequate drug retention within liposomes, especially in the case of long-circulating ones, is not achieved, the therapeutic index decreases substantially. Anticancer drug doxorubicin precipitates in the liposome interior in a form of gel with low solubility product and practically does not leak out in blood circulation in the scale of days. With an antibiotic, ciprofloxacin, the high loading efficacy and test tube stability is not reproduced in in vitro plasma leakage assays and in vivo. We believe that the reasons are higher solubility product of precipitated drug in the liposome, larger fraction of neutral molecules due closer pK values of the drug with the pH conditions in the solutions and high membrane permeability of this molecule. High resolution cryoEM shows that encapsulated anticancer agent doxorubicin is precipitated in the form of bundles of parallel fibers while antibiotic ciprofloxacin shows globular precipitate. Doxorubicin gelatin also causes the change of vesicle shape.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488619     DOI: 10.1016/0005-2736(95)00159-z

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.

Authors:  Azadeh Kheirolomoom; Lisa M Mahakian; Chun-Yen Lai; Heather A Lindfors; Jai Woong Seo; Eric E Paoli; Katherine D Watson; Eric M Haynam; Elizabeth S Ingham; Li Xing; R Holland Cheng; Alexander D Borowsky; Robert D Cardiff; Katherine W Ferrara
Journal:  Mol Pharm       Date:  2010-12-06       Impact factor: 4.939

2.  Protein encapsulation in unilamellar liposomes: high encapsulation efficiency and a novel technique to assess lipid-protein interaction.

Authors:  Xiaoming Xu; Antonio Costa; Diane J Burgess
Journal:  Pharm Res       Date:  2012-03-09       Impact factor: 4.200

3.  Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia.

Authors:  Azadeh Kheirolomoom; Chun-Yen Lai; Sarah M Tam; Lisa M Mahakian; Elizabeth S Ingham; Katherine D Watson; Katherine W Ferrara
Journal:  J Control Release       Date:  2013-08-28       Impact factor: 9.776

Review 4.  Drug transport to brain with targeted liposomes.

Authors:  Anita Schnyder; Jörg Huwyler
Journal:  NeuroRx       Date:  2005-01

5.  Liposome-Mediated Chemotherapeutic Delivery Is Synergistically Enhanced by Ternary Lipid Compositions and Cationic Lipids.

Authors:  Andrea N Trementozzi; Zachary I Imam; Morgan Mendicino; Carl C Hayden; Jeanne C Stachowiak
Journal:  Langmuir       Date:  2019-09-13       Impact factor: 3.882

6.  Evolution and Clinical Translation of Drug Delivery Nanomaterials.

Authors:  Shabir Hassan; Gyan Prakash; Aycabal Ozturk; Saghi Saghazadeh; Mohammad Farhan Sohail; Jungmok Seo; Mehmet Dockmeci; Yu Shrike Zhang; Ali Khademhosseini
Journal:  Nano Today       Date:  2017-08-02       Impact factor: 20.722

7.  Ciprofloxacin metalloantibiotic: an effective antibiotic with an influx route strongly dependent on lipid interaction?

Authors:  Mariana Ferreira; Paula Gameiro
Journal:  J Membr Biol       Date:  2014-11-07       Impact factor: 1.843

Review 8.  Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies.

Authors:  Alberto Gabizon; Hilary Shmeeda; Yechezkel Barenholz
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 9.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

10.  Microfluidic remote loading for rapid single-step liposomal drug preparation.

Authors:  R R Hood; W N Vreeland; D L DeVoe
Journal:  Lab Chip       Date:  2014-09-07       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.